# Second-generation Drug-eluting Stents in Diabetes

> **NCT03321032** · PHASE4 · UNKNOWN · sponsor: **Spanish Society of Cardiology** · enrollment: 1164 (estimated)

## Conditions studied

- Coronary Artery Disease
- Diabetes Mellitus

## Interventions

- **DEVICE:** Polymer-free amphilimus-eluting stents
- **DEVICE:** Biolinx Polymer-based zotarolimus-eluting stents

## Key facts

- **NCT ID:** NCT03321032
- **Lead sponsor:** Spanish Society of Cardiology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-19
- **Primary completion:** 2021-01-28
- **Final completion:** 2022-01-28
- **Target enrollment:** 1164 (ESTIMATED)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321032, "Second-generation Drug-eluting Stents in Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03321032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*